Getting a handle on rising drug plan costs

Roundtable looks at options for employers, including evidence-based drug plans, financial disincentives and pharmacy networks
By Liz Bernier
|Canadian HR Reporter|Last Updated: 07/06/2016

There’s no question the cost of drug plans is increasing considerably, if not accelerating — especially when it comes to specialty medications.

So, how can employers slow down the spend increases while still offering competitive benefits packages? 

A recent roundtable in Toronto, moderated by Sarah Dobson, editor/supervisor at Canadian HR Reporter, and sponsored by Sun Life Financial, delved into this and other questions.